Immunohistochemistry can sub-classify diffuse large B-cell lymphoma (DLBCL) into germinal centre B-cell like (GCB) and non-GCB subtypes. The latter consists predominately of the activated B-cell like subgroup in which nuclear factor kappa-B activation is its characteristic. Expression of cellular caspase 8 (FLICE)-like inhibitory protein (cFLIP), a caspase 8 homologue, is regulated by nuclear factor kappa-B signalling, and it is the main inhibitor of Fas ligand activated apoptosis. To determine if cFLIP expression was confined to non-GCB subtype, we studied 66 cases of DLBCL. cFLIP expression showed no significant correlation to DLBCL subtypes (GCB or non-GCB) but was associated with a worse clinical outcome. For cFLIP positive and negative patients, the five-year event free survival was 20 and 31%, respectively (p = 0.049), and the five-year overall survival was 20 and 57%, respectively (p = 0.041).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hon.996 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer.
NPJ Precis Oncol
December 2024
Department of Molecular Biosciences, The University of Kansas, Lawrence, KS, USA.
Triple-negative breast cancer (TNBC) presents therapeutic challenges due to limited targeted treatment options and resistance to chemotherapy drugs, such as doxorubicin. This study investigated doxorubicin resistance mechanisms and a strategy to overcome it. A doxorubicin-resistant cell subline (231-DR) was developed from MDA-MB-231 TNBC cells, and enhanced expression of cellular FLICE-inhibitory protein (cFLIP) in 231-DR cells was identified as a potential driver of the resistance.
View Article and Find Full Text PDFRNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer.
Cell Commun Signal
December 2024
Department of Molecular Biosciences, The University of Kansas, Lawrence, KS, 66045-7534, USA.
Article Synopsis
- The RNA-binding protein HuR is crucial in cancer progression, often preventing cell death, and its inhibition can lead to cancer cell death, which is not fully understood.
- The study explored the effects of the small molecule inhibitor KH-3 on various cancer cell lines, particularly breast and prostate cancers, finding that it induced cell death through apoptotic mechanisms, autophagy, and ferroptosis.
- KH-3's effectiveness was confirmed in mouse models and was linked to reduced levels of HuR target proteins involved in cell survival, suggesting that inhibiting HuR may serve as a potential cancer treatment strategy.
The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology.
Int Immunopharmacol
January 2025
Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates. Electronic address:
CAR T cell therapy has revolutionized how we deliver cancer treatment, most notably for hematologic cancers, by compelling T cells to recognize and kill tumor cells. Nevertheless, current obstacles to utilizing this therapy in solid tumors and overcoming cancer resistance include radicalization. This review discusses how CD95 modulation can boost CAR T cell efficacy.
View Article and Find Full Text PDFRNA-Seq Reveals Transcriptome Changes Following Zika Virus Infection in Fetal Brains in Knockdown Mice.
Viruses
October 2024
School of Public Health (Shenzhen), Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Article Synopsis
- c-FLIP is an important protein involved in processes like cell death (apoptosis) and inflammation, but its full effects on gene expression are not well understood.
- This study compared gene expression profiles in normal and c-FLIP deficient mice during Zika virus (ZIKV) infection, finding significant changes related to immune responses and organ development.
- The research suggests that c-FLIP plays a role in both the body's initial (innate) and adaptive immune responses during viral infections and may contribute to developmental issues caused by ZIKV.
Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer.
J Adv Res
November 2024
School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China. Electronic address:
Introduction: Triple-negative breast cancer (TNBC) has a high mortality rate and limited treatment options. Tetrahydrocurcumin (THC), a major metabolite of curcumin, has potential antitumor activities. However, the antitumor effects and mechanism of THC in TNBC remain elusive.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!